- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 10 Form of Perfomance Share Units Agreement for the 2012-2014 Performance Cyle
- 10 Form of Restricted Stock Units Agreement with Five Year Vesting
- 10 Form of Restricted Stock Units Agreement with Four Year Vesting
- 10 Form of Market Share Units
- 10 Senior Executive Severance Plan
- 12 Statement Re Computation of Ratios
- 21 Subsidiaries
- 23 Consent of Deloitte & Touche LLP
- 31 Section 302 Certification Letter
- 31 Section 302 Certification Letter
- 32 Section 906 Certification Letter
- 32 Section 906 Certification Letter
EXHIBIT 32b.
Certification by the Chief Financial Officer Pursuant to 18 U. S. C. Section 1350, as
Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U. S. C. Section 1350, I, Charles Bancroft, hereby certify that, to the best of my knowledge, Bristol-Myers Squibb Company’s Annual Report on Form 10-K for the year ended December 31, 2011 (the Report), as filed with the Securities and Exchange Commission on February 17, 2012, fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Bristol-Myers Squibb Company.
/s/ CHARLES BANCROFT |
Charles Bancroft |
Chief Financial Officer February 17, 2012 |
E-32-2